Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Danny Chui
Introduction
Danny Chui is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for cancer treatment. His work focuses on antibody-drug conjugates, which are designed to target specific receptors in cancer cells.
Latest Patents
Danny Chui holds a patent for "Antibody-drug conjugates targeting folate receptor alpha and methods of use." This patent describes antibody-drug conjugates (ADCs) that comprise an antibody construct specifically binding to the human folate receptor alpha (FRα). The ADCs are particularly useful as therapeutics in the treatment of cancer, utilizing a camptothecin analogue for enhanced efficacy.
Career Highlights
Chui is currently employed at Zymeworks BC Inc., a company known for its innovative approaches in the biopharmaceutical industry. His work at Zymeworks has allowed him to contribute to the advancement of targeted cancer therapies, showcasing his expertise in the field.
Collaborations
Danny collaborates with talented professionals, including James R. Rich and Stuart Daniel Barnscher. These collaborations enhance the research and development efforts at Zymeworks, fostering an environment of innovation and discovery.
Conclusion
Danny Chui's contributions to the field of biotechnology, particularly through his patent on antibody-drug conjugates, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment, demonstrating the impact of innovative thinking in the medical field.